I must admit to getting a bit worried about the low volume price increase for a little while there.
However, the roadshow/presentations obviously had the desired effect and I would imagine we have at least one or two institutions now on board, soaking up everything around the 5c mark (especially that 8 million plus volume yesterday).
The director tucking another million shares away into his super account at circa 5c also provides a great deal of comfort.
Realistically, information wise, we are pretty much where we were when BOT first reverse listed, but knowing these guys and what I expect is going on behind the scenes, I can't wait to start getting the announcements about further progress and trials.
All going to script at this stage, but the burning question of course is does the product work....yes, and we have ourselves a monster of a company.
Surely they must have enough pre-clinical data to feel confident that it will as expected?
Milesy
BOT Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)